Free shipping on all orders over $ 500

Urabrelimab

Cat. No. M25034

All AbMole products are for research use only, cannot be used for human consumption.

Urabrelimab Structure
Synonym:

SRF-231; SRF231

Size Price Availability Quantity
100ug USD 190  USD190 In stock
5mg USD 800  USD800 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Urabrelimab (SRF231) is a fully human anti-CD47 monoclonal antibody that blocks the CD47-SIRP interaction.

Chemical Information
CAS Number 2249722-58-3
Form Liquid
Storage Store at -80°C for 2 years. Avoid repeated freeze-thaw cycles.
Related IL Receptor/Related Products
IL-17A modulator-2

IL-17A modulator-2 is a IL-17A modulator. IL-17A modulator-2 inhibits the biological action of IL-17A with a pIC50 of 8.3. IL-17A modulator-2 can be used for the research of diseases associated with modulation of IL-17A activity.

IL-15-IN-1 

IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.

IL-17 modulator 3 

IL-17 modulator 3 is an IL-17 modulator.

IL-17 modulator 4 

IL-17 modulator 4 is a proagent of IL-17 modulator 1. IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator. IL-17 modulator 4 is promising for the research of IL-17A mediated diseases, including inflammation, autoimmune diseases, infectious diseases, cancer, and precancerous syndrome.

IL-17A modulator-3 

IL-17A modulator-3 is a IL-17A modulator.

  Catalog
Abmole Inhibitor Catalog




Keywords: Urabrelimab, SRF-231; SRF231 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.